Use of levothyroxine for euthyroid, thyroid antibody positive women with infertility: Analyses of aggregate data from a survey of European thyroid specialists (Treatment of Hypothyroidism in Europe by Specialists: An International Survey)
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
38856700
DOI
10.1111/cen.15099
Knihovny.cz E-zdroje
- Klíčová slova
- antithyroid antibodies, female infertility, levothyroxine, survey, thyroid hormone, treatment,
- MeSH
- autoprotilátky * krev MeSH
- dospělí MeSH
- hypotyreóza * farmakoterapie krev MeSH
- jodidperoxidasa imunologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- průzkumy a dotazníky MeSH
- thyroxin * terapeutické užití MeSH
- ženská infertilita * farmakoterapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa MeSH
- Názvy látek
- autoprotilátky * MeSH
- jodidperoxidasa MeSH
- thyroxin * MeSH
OBJECTIVES: The use of levothyroxine (LT4) treatment aiming to improve fertility in euthyroid women with positive thyroid peroxidase antibodies (TPOAb) is not supported by the available evidence. The aim of the study was to document the use of LT4 by European thyroid specialists in such patients. DESIGN: The data presented derive from Treatment of Hypothyroidism in Europe by Specialists, an International Survey (THESIS), a questionnaire conducted between 2019 and 2021 to document the management of hypothyroidism by European thyroid specialists. Here, we report the aggregate results on the use of LT4 in infertile, euthyroid women with positive TPOAb. RESULTS: A total of 2316/5406 (42.8%) respondents stated that LT4 may be indicated in TPOAb positive euthyroid women with infertility. The proportion of those replying positively to this question varied widely across different countries (median 39.4, range 22.9%-83.7%). In multivariate analyses males (OR: 0.8; CI: 0.7-0.9) and respondents >60 years (OR: 0.7; 0.6-0.8) were the least inclined to consider LT4 for this indication. Conversely, respondents managing many thyroid patients ("weekly" [OR: 1.4; CI: 1.0-1.9], "daily" [OR: 1.8; CI: 1.3-2.4]) and practicing in Eastern Europe (OR: 1.5; CI: 1.3-1.9) were most likely to consider LT4. CONCLUSIONS: A remarkably high number of respondents surveyed between 2019 and 2021, would consider LT4 treatment in TPOAb positive euthyroid women with infertility. This view varied widely across countries and correlated with sex, age and workload, potentially influencing patient management. These results raise concerns about potential risks of overtreatment.
Cabinet Médical 2 rue Bellefontaine Lausanne Switzerland
Department of Endocrinology and Metabolism Koru Ankara Hospital Ankara Turkey
Department of Endocrinology and Metabolism Regina Apostolorum Hospital Albano Laziale Rome Italy
Department of Endocrinology and Nutrition Université Catholique de Louvain Brussels Belgium
Department of Endocrinology Belarusian State Medical University Minsk Republic of Belarus
Department of Endocrinology Carol Davila University of Medicine and Pharmacy Bucharest Romania
Department of Endocrinology Diabetes Centre Hellenic Red Cross Hospital Athens Greece
Department of Endocrinology Hospital Universitario Puerta de Hierro Majadahonda Madrid Spain
Department of Endocrinology Odense University Hospital Odense Denmark
Department of Endocrinology Skåne University Hospital Malmö Sweden
Department of Endocrinology Tampere University Hospital Tampere Finland
Department of Internal Medicine and Endocrinology Medical University of Warsaw Warsaw Poland
Department of Internal Medicine Endocrine Unit Brussel Belgium
Department of Medicine Universidad Autónoma de Madrid Madrid Spain
Department of Surgery Tampere University Hospital Tampere Finland
Diabetes and Endocrinology Section Beacon Hospital Dublin Ireland
Division of Endocrinology Diabetes and Metabolism University of Lausanne Lausanne Switzerland
Division of Endocrinology Presidio Ospedaliero 5 Fazzi Lecce Italy
East Surrey Hospital Surrey and Sussex Healthcare NHS Trust Redhill Surrey UK
Endocrine Department St Vincent's University Hospital Dublin Ireland
Faculty of Medicine University of Belgrade Belgrade Serbia
Institute of Translational and Clinical Research Newcastle University Newcastle upon Tyne UK
Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana Majadahonda Spain
Rabin Medical Center Hasharon Campus Petach Tikva Israel
Robert Graves Institute Tallaght University Hospital Dublin Ireland
School of Medicine University College Dublin Dublin Ireland
Scientific Committee Associazione Medici Endocrinologi Milan Italy
Zobrazit více v PubMed
Silva JF, Ocarino NM, Serakides R. Thyroid hormones and female reproduction. Biol Reprod. 2018;99:907‐921.
Krassas GE, Pontikides N, Kaltsas T, Papadopoulou P, Batrinos M. Menstrual disturbances in thyrotoxicosis. Clin Endocrinol. 1994;40:641‐644.
Krassas GE, Pontikides N, Kaltsas T, et al. Disturbances of menstruation in hypothyroidism. Clin Endocrinol. 1999;50:655‐659.
Ylöstalo P, Kujala P, Kontula K. Amenorrhea with low normal thyroid function and thyroxine treatment. Int J Gynecol Obstet. 1980;18:176‐180.
Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489‐499.
Available at: https://ec.europa.eu/eurostat/web/products-eurostat-news/-/ddn-20200515-2
Petta CA, Arruda MS, Zantut‐Wittmann DE, Benetti‐Pinto CL. Thyroid autoimmunity and thyroid dysfunction in women with endometriosis. Hum Reprod. 2007;22:2693‐2697.
Romitti M, Fabris VC, Ziegelmann PK, Maia AL, Spritzer PM. Association between PCOS and autoimmune thyroid disease: a systematic review and meta‐analysis. Endocr Connect. 2018;7:1158‐1167.
Rao M, Wang H, Zhao S, et al. Subclinical hypothyroidism is associated with lower ovarian reserve in women aged 35 years or older. Thyroid. 2020;30:95‐105.
Doufas AG, Mastorakos G. The hypothalamic‐pituitary‐thyroid axis and the female reproductive system. Ann NY Acad Sci. 2000;900:65‐76.
Colicchia M, Campagnolo L, Baldini E, Ulisse S, Valensise H, Moretti C. Molecular basis of thyrotropin and thyroid hormone action during implantation and early development. Hum Reprod Update. 2014;20:884‐904.
Korevaar TIM, Medici M, Visser TJ, Peeters RP. Thyroid disease in pregnancy: new insights in diagnosis and clinical management. Nat Rev Endocrinol. 2017;13:610‐622.
Medici M, Korevaar TIM, Visser WE, Visser TJ, Peeters RP. Thyroid function in pregnancy: what is normal? Clin Chem. 2015;61:704‐713.
Korevaar TI, Steegers EA, Pop VJ, et al. Thyroid autoimmunity impairs the thyroidal response to human chorionic gonadotropin: two population‐based prospective cohort studies. J Clin Endocrinol Metab. 2017;102:69‐77.
Li D, Hu S, Meng X, Yu X. Changes in thyroid function during controlled ovarian hyperstimulation (COH) and its impact on assisted reproduction technology (ART) outcomes: a systematic review and meta‐analysis. J Assist Reprod Genet. 2021;38:2227‐2235.
Consortium on Thyroid and Pregnancy—Study Group on Preterm Birth, Korevaar, TIM, Derakhshan A, et al. Association of thyroid function test abnormalities and thyroid autoimmunity with preterm birth: a systematic review and meta‐analysis. JAMA. 2019;322:632‐641.
Zhang Y, Wang H, Pan X, Teng W, Shan Z. Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: a systematic review and meta‐analysis. PLoS One. 2017;12:e0175708.
Rao M, Zeng Z, Zhou F, et al. Effect of levothyroxine supplementation on pregnancy loss and preterm birth in women with subclinical hypothyroidism and thyroid autoimmunity: a systematic review and meta‐analysis. Hum Reprod Update. 2019;25:344‐361.
Rao M, Zeng Z, Zhao S, Tang L. Effect of levothyroxine supplementation on pregnancy outcomes in women with subclinical hypothyroidism and thyroid autoimmuneity undergoing in vitro fertilization/intracytoplasmic sperm injection: an updated meta‐analysis of randomized controlled trials. Reprod Biol Endocrinol. 2018;16:92.
Velkeniers B, Van Meerhaeghe A, Poppe K, Unuane D, Tournaye H, Haentjens P. Levothyroxine treatment and pregnancy outcome in women with subclinical hypothyroidism undergoing assisted reproduction technologies: systematic review and meta‐analysis of RCTs. Hum Reprod Update. 2013;19:251‐258.
Reid SM, Middleton P, Cossich MC, Crowther CA, Bain E. Interventions for clinical and subclinical hypothyroidism pre‐pregnancy and during pregnancy. Cochrane Database Syst Rev. 2013;5:CD007752.
Alexander EK, Pearce EN, Brent GA, et al. 2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27:315‐389.
Dhillon‐Smith RK, Middleton LJ, Sunner KK, et al. Levothyroxine in women with thyroid peroxidase antibodies before conception. N Engl J Med. 2019;380:1316‐1325.
van Dijk MM, Vissenberg R, Fliers E, et al. Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double‐blind, placebocontrolled, phase 3 trial. Lancet Diabetes Endocrinol. 2022;10:322‐329.
Wang H, Gao H, Chi H, et al. Effect of levothyroxine on miscarriage among women with normal thyroid function and thyroid autoimmunity undergoing in vitro fertilization and embryo transfer: a randomized clinical trial. JAMA. 2017;318:2190‐2198.
Negro R, Attanasio R, Nagy EV, Papini E, Perros P, Hegedüs L. Use of thyroid hormones in hypothyroid and euthyroid patients; the 2019 Italian survey. Eur Thyroid J. 2020;9:25‐31.
Zarkovic M, Attanasio R, Nagy EV, et al. Characteristics of specialists treating hypothyroid patients: the “THESIS” collaboration. Front Endocrinol. 2023;714:1225202.
https://unstats.un.org/unsd/methodology/m49/
Poppe K, Bisschop P, Fugazzola L, Minziori G, Unuane D, Weghofer A. 2021 European Thyroid Association Guideline on thyroid disorders prior to and during assisted reproduction. Eur Thyroid J. 2021;9:281‐295.
Yang Y, Guo T, Fu J, et al. Association of preconception thyrotropin levels with fecundability and risk of spontaneous abortion in China. JAMA Netw Open. 2022;5:e2228892.
Yang Y, Guo T, Fu J, et al. Preconception thyrotropin levels and risk of adverse pregnancy outcomes in Chinese women aged 20 to 49 years. JAMA Netw Open. 2021;4:e215723.
Maraka S, Mwangi R, McCoy RG, et al. Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment. BMJ. 2017;356:i6865.
Derakhshan A, Peeters RP, Taylor PN, et al. Association of maternal thyroid function with birthweight: a systematic review and individual‐participant data meta‐analysis. Lancet Diabetes Endocrinol. 2020;8:501‐510.
Hales C, Taylor PN, Channon S, et al. Controlled antenatal thyroid screening II: effect of treating maternal suboptimal thyroid function on child behavior. J Clin Endocrinol Metab. 2020;105:e417‐e427.
Korevaar TIM, Muetzel R, Medici M, et al. Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population‐based prospective cohort study. Lancet Diabetes Endocrinol. 2016;4:35‐43.
Lillevang‐Johansen M, Abrahamsen B, Jørgensen HL, Brix TH, Hegedüs L. Duration of over‐ and under‐treatment of hypothyroidism is associated with increased cardiovascular risk. Eur J Endocrinol. 2019;180:407‐416.
Gill S, Cheed V, Morton VAH, et al. Evaluating the progression to hypothyroidism in preconception euthyroid thyroid peroxidase antibody‐positive women. J Clin Endocrinol Metab. 2022;108:124‐134.
Hubalewska‐Dydejczyk A, Trofimiuk‐Müldner M, Ruchala M, et al. Thyroid diseases in pregnancy: guidelines of the Polish Society of endocrinology. Endokrynol Pol. 2021;72:425‐488.
Hajjaj F, Salek M, Basra M, Finlay A. Non‐clinical influences on clinical decision‐making: a major challenge to evidence‐based practice. J R Soc Med. 2010;103:178‐187.
Escher M, Perneger TV, Chevrolet JC. National questionnaire survey on what influences doctors' decisions about admission to intensive care. BMJ. 2004;329:425.
Petursson P. GPs' reasons for “non‐pharmacological” prescribing of antibiotics. A phenomenological study. Scand J Prim Health Care. 2005;23:120‐125.
Tracy CS, Dantas GC, Moineddin R, Upshur RE. Contextual factors in clinical decision making: national survey of Canadian family physicians. Can Fam Physician. 2005;51:1106‐1107.
Bensing JM, Den brink‐Muinen AV, de Bakker DH. Gender differences in practice style: a Dutch study of general practitioners. Med Care. 1993;31:219‐229.
Franks P, Bertakis KD. Physician gender, patient gender, and primary care. J Women's Health. 2003;12:73‐80.